Esperion Therapeutics
ESPR • NASDAQ • Stock Fundamentals
Esperion Therapeutics is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Sheldon L. Koenig, with a market cap of $811.7M.
Market Cap$811.7M
Employees240.0
CEOSheldon L. Koenig
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 8, 2026 · 1 month 6 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Esperion Therapeutics FAQ
Common questions about Esperion Therapeutics
Esperion Therapeutics (ESPR) has a market capitalization of $811.7M and trades on NASDAQ.
Esperion Therapeutics has approximately 240 employees.